SEC Form 4 · accession 0001209191-16-088671
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Tarriff
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.31 | Dec 31, 2015 | A | 40,000 | A | — | Dec 31, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F140,000 shares shall vest on 12/31/2016.